Cargando…

Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization

Splenic rupture can be categorized into two groups: traumatic and atraumatic. Traumatic rupture is frequently associated with blunt abdominal trauma, while atraumatic splenic rupture (ASR) is more uncommon and has been associated with both benign and malignant hematological disorders. In general, mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Yunan, Kent, Andrew, Do, Minh, Amaya, Maria, Klein, Catherine, Thienelt, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035913/
https://www.ncbi.nlm.nih.gov/pubmed/35529292
http://dx.doi.org/10.1159/000522663
_version_ 1784693404850978816
author Nie, Yunan
Kent, Andrew
Do, Minh
Amaya, Maria
Klein, Catherine
Thienelt, Christiane
author_facet Nie, Yunan
Kent, Andrew
Do, Minh
Amaya, Maria
Klein, Catherine
Thienelt, Christiane
author_sort Nie, Yunan
collection PubMed
description Splenic rupture can be categorized into two groups: traumatic and atraumatic. Traumatic rupture is frequently associated with blunt abdominal trauma, while atraumatic splenic rupture (ASR) is more uncommon and has been associated with both benign and malignant hematological disorders. In general, most cases of splenic rupture are managed with splenectomy, which carries significant mortality and morbidity; more recently, splenic artery embolization (SAE) has become a mainstay of management particularly after traumatic rupture. We describe a patient with chronic myelomonocytic leukemia (CMML) who presented to the emergency department for acute abdominal pain and was found to have an ASR. He underwent partial SAE, with postoperative complications of leukocytosis and tumor lysis syndrome (TLS) requiring rasburicase and allopurinol. On follow-up in clinic 2 months post-discharge, the patient was doing well on hydroxyurea, without need for further intervention at that time. In patients with hematologic malignancies presenting with abdominal pain and splenomegaly, it is important to consider ASR as a rare, but possible complication. To our knowledge, this is the only reported patient treated with SAE in the context of ASR from CMML, demonstrating that SAE can be an effective nonoperative strategy for treatment of CMML-associated ASR. This case report also highlights postoperative complications and management in this patient population, specifically a profound leukocytosis and TLS, for which close monitoring should be performed.
format Online
Article
Text
id pubmed-9035913
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-90359132022-05-06 Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization Nie, Yunan Kent, Andrew Do, Minh Amaya, Maria Klein, Catherine Thienelt, Christiane Case Rep Oncol Case Report Splenic rupture can be categorized into two groups: traumatic and atraumatic. Traumatic rupture is frequently associated with blunt abdominal trauma, while atraumatic splenic rupture (ASR) is more uncommon and has been associated with both benign and malignant hematological disorders. In general, most cases of splenic rupture are managed with splenectomy, which carries significant mortality and morbidity; more recently, splenic artery embolization (SAE) has become a mainstay of management particularly after traumatic rupture. We describe a patient with chronic myelomonocytic leukemia (CMML) who presented to the emergency department for acute abdominal pain and was found to have an ASR. He underwent partial SAE, with postoperative complications of leukocytosis and tumor lysis syndrome (TLS) requiring rasburicase and allopurinol. On follow-up in clinic 2 months post-discharge, the patient was doing well on hydroxyurea, without need for further intervention at that time. In patients with hematologic malignancies presenting with abdominal pain and splenomegaly, it is important to consider ASR as a rare, but possible complication. To our knowledge, this is the only reported patient treated with SAE in the context of ASR from CMML, demonstrating that SAE can be an effective nonoperative strategy for treatment of CMML-associated ASR. This case report also highlights postoperative complications and management in this patient population, specifically a profound leukocytosis and TLS, for which close monitoring should be performed. S. Karger AG 2022-03-21 /pmc/articles/PMC9035913/ /pubmed/35529292 http://dx.doi.org/10.1159/000522663 Text en Copyright © 2022 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Nie, Yunan
Kent, Andrew
Do, Minh
Amaya, Maria
Klein, Catherine
Thienelt, Christiane
Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization
title Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization
title_full Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization
title_fullStr Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization
title_full_unstemmed Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization
title_short Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization
title_sort atraumatic splenic rupture due to chronic myelomonocytic leukemia treated with partial splenic artery embolization
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035913/
https://www.ncbi.nlm.nih.gov/pubmed/35529292
http://dx.doi.org/10.1159/000522663
work_keys_str_mv AT nieyunan atraumaticsplenicruptureduetochronicmyelomonocyticleukemiatreatedwithpartialsplenicarteryembolization
AT kentandrew atraumaticsplenicruptureduetochronicmyelomonocyticleukemiatreatedwithpartialsplenicarteryembolization
AT dominh atraumaticsplenicruptureduetochronicmyelomonocyticleukemiatreatedwithpartialsplenicarteryembolization
AT amayamaria atraumaticsplenicruptureduetochronicmyelomonocyticleukemiatreatedwithpartialsplenicarteryembolization
AT kleincatherine atraumaticsplenicruptureduetochronicmyelomonocyticleukemiatreatedwithpartialsplenicarteryembolization
AT thieneltchristiane atraumaticsplenicruptureduetochronicmyelomonocyticleukemiatreatedwithpartialsplenicarteryembolization